Skip to content
Clinical Trials – home

Algesiologikum MVZ GmbH

Verified siteinfo

Germany Hessstrasse 22, Maxvorstadt, 80799 Munich, Germany

  • Pain · Neuropathy peripheral · Back pain
  • Adult patients

About Specializations

Algesiologikum MVZ GmbH in Munich, Germany specialises in clinical trials of conditions such as Pain, Neuropathy peripheral, Back pain, Diabetic neuropathy, and other specialisations. This site conducts important research.

Main research areas of the site

Diseases and Pain-Related Conditions

At Algesiologikum MVZ GmbH in Munich, clinical research is focused on pathological conditions and signs and symptoms linked to persistent pain. The studies center on understanding and improving care for people living with long-lasting pain disorders, with an emphasis on evaluating new treatment options that may offer better symptom control and daily function.

  • Chronic pain due to diabetic polyneuropathy
  • Chronic pain due to traumatic or post-operative peripheral neuropathy
  • Chronic back pain
  • Chronic pain due to central neuropathy of any origin

The site is conducting trials that assess the effectiveness and tolerability of a new add-on therapy, aiming to support better treatment outcomes for patients with complex chronic pain conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Hessstrasse 22, Maxvorstadt80799 MunichGermany
Recruiting now
no trials
Conditions studied
4
Partner status
Verified site

More sites in MunichGermany

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Back pain

Not recruiting

Study on the Effectiveness and Safety of AP707 and Naproxen for Patients with Chronic Back Pain

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Aceclofenac
  • Sponsor:Apurano Pharmaceuticals GmbH

Pain+1

Not recruiting

Study on the Effectiveness and Safety of AP707 with Lamotrigine and Amitriptyline for Patients with Chronic Central Neuropathic Pain

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Adezunap
  • Sponsor:Apurano Pharmaceuticals GmbH

Pain+1

Not recruiting

Study on the Effectiveness of AP707, Gabapentin, and Capsaicin for Patients with Chronic Pain from Traumatic or Post-Operative Peripheral Neuropathy

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Adezunap
  • Sponsor:Apurano Pharmaceuticals GmbH

Diabetic neuropathy+1

Not recruiting

Study on the Effectiveness and Safety of AP707, Amitriptyline, and Capsaicin for Patients with Chronic Pain from Diabetic Neuropathy

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Adezunap
  • Sponsor:Apurano Pharmaceuticals GmbH
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.